An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...